These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11256683)

  • 21. Effect of nimodipine, a dihydropyridine calcium channel antagonist, on the steady state pharmacokinetics of phenytoin (DPH) in rhesus monkeys.
    Gupta MC; Garg SK
    Methods Find Exp Clin Pharmacol; 1999; 21(6):453-5. PubMed ID: 10445240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nimodipine at a dose that slows ABR latencies does not protect the ear against noise.
    Ison JR; Payman GH; Palmer MJ; Walton JP
    Hear Res; 1997 Apr; 106(1-2):179-83. PubMed ID: 9112117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
    Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.
    Cipriani A; Saunders K; Attenburrow MJ; Stefaniak J; Panchal P; Stockton S; Lane TA; Tunbridge EM; Geddes JR; Harrison PJ
    Mol Psychiatry; 2016 Oct; 21(10):1324-32. PubMed ID: 27240535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In brief: nimodipine oral solution (Nymalize).
    Med Lett Drugs Ther; 2013 Aug; 55(1423):68. PubMed ID: 23959389
    [No Abstract]   [Full Text] [Related]  

  • 26. Nimodipine ameliorates trauma-induced cochlear neuronal death.
    Sekiya T; Yagihashi A; Asano K; Suzuki S
    Neurol Res; 2002 Dec; 24(8):775-80. PubMed ID: 12500700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of nimodipine, a dihydropyridine calcium channel antagonist on the pharmacokinetics of carbamazepine in rhesus monkeys.
    Gupta MC; Garg SK; Das BP; Bhargava VK
    Indian J Physiol Pharmacol; 2003 Jul; 47(3):347-51. PubMed ID: 14723323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neurochemistry of mania. The effect of lithium on catecholamines, indoleamines and calcium mobilization.
    Wood K
    J Affect Disord; 1985; 8(3):215-23. PubMed ID: 2410470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of nimodipine in the medical treatment of Menière's disease: clinical experience.
    Lassen LF; Hirsch BE; Kamerer DB
    Am J Otol; 1996 Jul; 17(4):577-80. PubMed ID: 8841703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nimotop: clinical spectrum].
    Shirokov EA; Denishchuk IS; Polkhovskiĭ AA
    Klin Med (Mosk); 1998; 76(5):37-40. PubMed ID: 9644935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bipolar affective disorders and role of intraneuronal calcium. Therapeutic effects of the treatment with lithium salts and/or calcium antagonist in patients with rapid polar inversion].
    Manna V
    Minerva Med; 1991 Nov; 82(11):757-63. PubMed ID: 1766578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging trends in the treatment of rapid cycling bipolar disorder: a selected review.
    Post RM; Frye MA; Denicoff KD; Leverich GS; Dunn RT; Osuch EA; Speer AM; Obrocea G; Jajodia K
    Bipolar Disord; 2000 Dec; 2(4):305-15. PubMed ID: 11252642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by Ca(2+) antagonist nimodipine.
    Harkany T; Dijkstra IM; Oosterink BJ; Horvath KM; Abrahám I; Keijser J; Van der Zee EA; Luiten PG
    Neuroscience; 2000; 101(1):101-14. PubMed ID: 11068140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-finding study with nimodipine: a selective central nervous system calcium channel blocker on aminophylline induced seizure models in rats.
    Chakrabarti A; Saini HK; Garg SK
    Brain Res Bull; 1998 Mar; 45(5):495-9. PubMed ID: 9570719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nimodipine does not affect the flow-metabolism couple in permanent cerebral ischemia.
    Gomi S; Burnett MG; Karp A; Greenberg JH
    Exp Brain Res; 2004 Apr; 155(4):469-76. PubMed ID: 14752581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recurrent reversible posterior encephalopathy syndrome with a response to nimodipine].
    Matias-Guiu JA; García-Ptacek S; Ordás CM; Marcos-Dolado A; Porta-Etessam J
    Neurologia; 2012; 27(6):378-80. PubMed ID: 22341988
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of nimodipine on calcium homeostasis and pain sensitivity in diabetic rats.
    Shutov L; Kruglikov I; Gryshchenko O; Khomula E; Viatchenko-Karpinski V; Belan P; Voitenko N
    Cell Mol Neurobiol; 2006; 26(7-8):1541-57. PubMed ID: 16838100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Calcium channel blockers in therapy of neurologic diseases].
    Wessely P; Wöber-Bingöl C
    Wien Med Wochenschr; 1993; 143(19-20):514-8. PubMed ID: 8135034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoglycaemic brain damage: effect of a dihydropyridine calcium channel antagonist in rats.
    Auer RN; Anderson LG
    Diabetologia; 1996 Feb; 39(2):129-34. PubMed ID: 8635663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of endothelin-1 and calcium channel blockers on contractions in human myometrium. A study on myometrial strips from normal and diabetic pregnant women.
    Kaya T; Cetin A; Cetin M; Sarioglu Y
    J Reprod Med; 1999 Feb; 44(2):115-21. PubMed ID: 10853442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.